VTGN · Vistagen Therapeutics, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had cash, cash equivalents, and marketable securities of approximately $31.7 million. As of August 14, 2026, the issuance date of the condensed consolidated financial statements in this Quarterly Report as of and for the three months ended June 30, 2026, there is uncertainty about whether our combined cash, cash equivalents, and marketable securities will be sufficient to fund operations beyond twelve months from the issuance date of the condensed consolidated financial statements in this Report and therefore we concluded that substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-29 | Williamson Douglas J |
Executive VP, Research & Dev |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. |
Stock Options (Right to Buy)
|
40,826 |
| 2026-06-30 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the "ESPP"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP. |
Common Stock
|
36,818 |
| 2026-06-30 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended (the "ESPP"), in a transaction exempt under Rule 16b-3 and Rule 16b-3(d). The Reporting Person purchased the maximum amount permitted under the ESPP. |
Common Stock
|
36,818 |
| 2026-06-30 | Tressler Nick B. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
11,712 |
| 2026-05-18 | Angelov Angel S |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The stock options were granted in connection with the Reporting Person's appointment as Chief Medical Officer. 25% of the stock options vest on May 18, 2027 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. |
Stock Option (Right to Buy)
|
150,000 |
| 2026-04-07 | Cote Elissa S. |
Chief Corp Development Officer |
Award↑
Filing footnotes — Incentive Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Incentive Stock Option (right to buy)
|
75,000 |
| 2026-04-07 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Non-Qualified Stock Option (right to buy)
|
71,268 |
| 2026-04-07 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Non-Qualified Stock Option (right to buy)
|
56,248 |
| 2026-04-07 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Incentive Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Incentive Stock Option (right to buy)
|
18,753 |
| 2026-04-07 | Tressler Nick B. |
Chief Financial Officer |
Award↑
Filing footnotes — Incentive Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Incentive Stock Option (right to buy)
|
75,000 |
| 2026-04-07 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Incentive Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Incentive Stock Option (right to buy)
|
3,732 |
| 2026-04-07 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Incentive Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Incentive Stock Option (right to buy)
|
18,752 |
| 2026-04-07 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. 25% of the Options will vest on the six-month anniversary of April 7, 2026 (the "Grant Date"), and will vest in 25% installments every six months thereafter until the Options become fully vested on the two (2) year anniversary of the Grant Date. |
Non-Qualified Stock Option (right to buy)
|
56,247 |
| 2025-12-31 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
4,386 |
| 2025-12-01 | Tressler Nick B. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer. 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. |
Common Stock (Right to Buy)
|
150,000 |
| 2025-10-27 | Edick Paul R |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options granted in connection with the reporting person's appointment to the Issuer's Board of Directors. The stock options were granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, and vest in three equal annual installments, beginning on the first anniversary of the date of the grant. |
Stock Option (Right to Buy)
|
35,200 |
| 2025-09-09 | FitzPatrick Margaret M |
Director |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Non-Qualified Stock Option (right to buy)
|
17,600 |
| 2025-09-09 | Rotunno Mary L. |
Director |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Non-Qualified Stock Option (right to buy)
|
17,600 |
| 2025-09-09 | Curley Joanne |
Chief Development Officer |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Non-Qualified Stock Option (right to buy)
|
17,600 |
| 2025-09-09 | Cunningham Ann Michelle |
Director |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Non-Qualified Stock Option (right to buy)
|
17,600 |
| 2025-09-09 | SAXE JON S |
Director |
Award↑
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Non-Qualified Stock Option (right to buy)
|
17,600 |
| 2025-06-30 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
7,541 |
| 2025-06-30 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
7,541 |
| 2025-06-30 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
4,882 |
| 2025-06-30 | Anderson Cynthia Lynn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
6,617 |
| 2025-06-23 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
100,000 |
| 2025-06-23 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
300,000 |
| 2025-06-23 | Anderson Cynthia Lynn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
100,000 |
| 2025-06-23 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
100,000 |
| 2025-06-23 | Cote Elissa S. |
Chief Corp Development Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The stock options were granted in connection with the Reporting Person's appointment as Chief Corporate Development Officer. 25% of the stock options vest on June 23, 2026 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. |
Stock Option (Right to Buy)
|
150,000 |
| 2024-12-31 | Anderson Cynthia Lynn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
2,592 |
| 2024-12-31 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d). |
Common Stock
|
3,310 |
| 2024-09-06 | SAXE JON S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-09-06 | FitzPatrick Margaret M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-09-06 | GIN JERRY B |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-09-06 | Rotunno Mary L. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-09-06 | Cunningham Ann Michelle |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-09-06 | Curley Joanne |
Chief Development Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date. |
Stock Option (Right to Buy)
|
14,100 |
| 2024-06-28 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. |
Common Stock
|
4,854 |
| 2024-06-28 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. |
Common Stock
|
4,854 |
| 2024-06-28 | Anderson Cynthia Lynn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. |
Common Stock
|
3,592 |
| 2024-06-28 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended. |
Common Stock
|
2,671 |
| 2024-06-24 | Adler Reid G. |
Chief Legal Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. |
Stock Option (Right to Buy)
|
170,000 |
| 2024-06-24 | Prince Joshua S. |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. |
Stock Option (Right to Buy)
|
150,000 |
| 2024-06-24 | Anderson Cynthia Lynn |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. |
Stock Option (Right to Buy)
|
150,000 |
| 2024-06-24 | Singh Shawn |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the "Vesting Start Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date. |
Stock Option (Right to Buy)
|
500,000 |
| 2024-03-04 | Curley Joanne |
Chief Development Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Stock Option (Right to Buy)
|
12,500 |
| 2024-03-04 | Cunningham Ann Michelle |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Stock Option (Right to Buy)
|
12,500 |
| 2024-03-04 | SAXE JON S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Stock Option (Right to Buy)
|
12,500 |
| 2024-03-04 | FitzPatrick Margaret M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant. |
Stock Option (Right to Buy)
|
12,500 |